Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ISRCTN14852868) titled 'The effects of probiotic supplementation on anxiety, depressive symptoms, and inflammatory markers' on Aug. 3.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: Parallel
Purpose: Treatment
Primary Sponsor: University General Hospital Attikon
Condition:
Symptoms of anxiety and/or depression
Mental and Behavioural Disorders
Intervention:
At baseline (t0), participants will undergo a clinical psychiatric interview to determine eligibility for inclusion in the study according to predefined inclusion and exclusion criteria...